Stock 897 WAI YUEN TONG MEDICINE HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Wai Yuen Tong Medicine Holdings Limited

Equities

897

BMG9421Y2332

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:35 22/05/2024 BST 		5-day change 1st Jan Change
0.225 HKD -0.88% Intraday chart for Wai Yuen Tong Medicine Holdings Limited -1.75% -43.75%
04-02 Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023. CI
03-28 Wai Yuen Tong Medicine Holdings Limited Announces Changes of Company Secretary, with Effect from 1 April 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023.
CI
Wai Yuen Tong Medicine Plans Special Dividend of Wang On, China Agri-Products Shares; Shares Up 7%
MT
Wai Yuen Tong Medicine Holdings Limited agreed to Spin-Off Wang On Group Limited.
CI
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.
CI
Wai Yuen Tong Medicine Returns to Profit in Fiscal H1
MT
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Wai Yuen Tong Medicine to Return to Profit in Fiscal H1
MT
Wai Yuen Tong Medicine Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2023
CI
Wai Yuen Tong Medicine Holdings Limited's Equity Buyback announced on September 1, 2022, has expired with 60,540,000 shares, representing 4.98% for HKD 24.69 million.
CI
Wai Yuen Tong Medicines' Fiscal Year 2023 Loss Narrows
MT
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.
CI
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Lei Wa entered completed the acquisition of Billion Good Investment Limited from Wai Yuen Tong Medicine Holdings Limited and Wang On Limited.
CI
Wai Yuen Tong Medicine to Narrow Full-Year Loss
MT
Wai Yuen Tong Medicine Holdings Limited Provides Earnings Guidance for the Financial Year Ended 31 March 2023
CI
Lei Wa entered into the Provisional Agreement to acquire Billion Good Investment Limited from Wai Yuen Tong Medicine Holdings Limited and Wang On Limited for HKD 71 million.
CI
Wai Yuen Tong Medicine Swings to Loss in April-September
MT
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2022
CI
Wai Yuen Tong Medicine Forecasts Swing to H1 Loss
MT
Wai Yuen Tong Medicine Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 897 Stock
  4. News Wai Yuen Tong Medicine Holdings Limited
  5. Highlights